Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

AI as a second set of eyes: could it sharpen pneumonia detection on chest X-Rays?

NCT ID NCT07744555

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 04, 2026 · Last updated Aug 05, 2026 · Updated 1 time

Summary

This trial tests whether an artificial intelligence system can help less-experienced doctors—like final-year medical students and early-career general practitioners—interpret chest X-rays more accurately. Participants will read the same set of X-rays twice: once with AI assistance and once without, to see if the AI improves their ability to spot and classify pulmonary opacities (signs of pneumonia). The study focuses on diagnostic accuracy and confidence, not on treatment decisions.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Artificial intelligence-based expert system for computer-aided interpretation of chest radiographs
What this could lead to
If it works, this could lead to a practical tool that helps less-experienced doctors spot pneumonia on chest X-rays more accurately, potentially improving diagnosis in settings where expert radiologists are scarce.
What could go wrong
This is a small study (50 participants) and the AI is only a decision-support tool—doctors still make the final call. The results may not generalize to all clinical settings, and the AI could potentially mislead if its output is incorrect.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 50 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2026

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Final-year undergraduate medical students. * Physicians completing mandatory rural or social service. * Licensed general practitioners with less than two years of clinical experience. * Willingness to participate as a chest radiograph reader. * Ability to complete both study reading sessions. Exclusion Criteria: * Corrected visual acuity worse than 20/60 in the better-seeing eye. * Visual-field restriction, impaired contrast perception, binocular vision abnormalities, or another visual condition that prevents adequate interpretation of chest radiographs. * Inability to complete the visual acuity assessment before the reading session.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pneumonia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Clínica Universidad de La Sabana

    Chía, Cundinamarca, 111321, Colombia

More trials for these conditions

Other studies related to the condition(s) this trial covers.